A 5-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
The aim of this study was to develop a fast, effective and material sparing screening method to design Amorphous Solid Dispersions (ASDs) of etravirine, in order to drive more effectively the development process, leading to improved bioavailability (BA), and stability. A systematic step-by-step approach was followed by combining theoretical calculations with high-throughput screening (HTS) and software-assisted multivariate statistical analysis. The thermodynamic miscibility and interaction of the drug in several polymers was predicted using Hansen solubility parameters (δ). The selected polymers were evaluated by HTS, using solvent evaporation. Binary compositions were evaluated by their solubilization capacity and physical stability over 2 months. JMP® 14.0 was used for multivariate statistical analysis using Principal Components Analysis. Extrusion was performed in Thermo Scientific HAAKE MiniLab II and extrudates characterized by assay, related substances, dissolution and physical state (PLM, Raman spectroscopy, and XRPD). A short stability study was performed where milled extrudates were exposed to 25ºC/60%RH and 40ºC/75%RH for 3 months. Through thermodynamic predictions, 5 main polymers were selected. The HTS enabled the evaluation of 42 formulations for solubilization capacity and physical stability. The 3 most promising compositions were selected for hot-melt extrusion (HME) tests. In general, a good correlation was found between the results of theoretical predictions, HTS, and HME. PVP-based formulations were shown to be easily extrudable, with low degradation and complete amorphicity, whereas in Soluplus, the drug was not miscible, leading to high crystalline content. The drug release rate was improved more than 2 times with PVP, and the manufactured ASD demonstrated to be stable physically and chemically. A fast and effective screening technique to develop stable ASDs for a poorly soluble drug was successfully developed as applied to etravirine. The given method is easy to use, requires a low amount of drug and is fairly accurate in predicting the amorphization of the drug when formulated. The success of HME formulation development of etravirine was undoubtedly enhanced with this high-throughput tool, which led to the identification of extrudates with improved biopharmaceutical properties. The structural characterization performed by PLM, XRPD and Raman spectroscopy demonstrated that the HME prototype was essentially amorphous. The unexpected stability at 40ºC/75%RH was correlated with the presence of molecular interaction characterized by Raman spectroscopy.